BR112012015693A8 - métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda - Google Patents

métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda

Info

Publication number
BR112012015693A8
BR112012015693A8 BR112012015693A BR112012015693A BR112012015693A8 BR 112012015693 A8 BR112012015693 A8 BR 112012015693A8 BR 112012015693 A BR112012015693 A BR 112012015693A BR 112012015693 A BR112012015693 A BR 112012015693A BR 112012015693 A8 BR112012015693 A8 BR 112012015693A8
Authority
BR
Brazil
Prior art keywords
kidney disease
canine
diagnosing
methods
probe
Prior art date
Application number
BR112012015693A
Other languages
English (en)
Other versions
BR112012015693A2 (pt
Inventor
Al-Murrani Samer
Malladi Sukhaswami
Gao Xiangming
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of BR112012015693A2 publication Critical patent/BR112012015693A2/pt
Publication of BR112012015693A8 publication Critical patent/BR112012015693A8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

composições e métodos para diagnosticar e tratar doença renal em um canico a presente invenção fornece métodos para: diagnosticar, elaborar e monitorar um plano de tratamento para, e monitorar o estado de uma doença renal caracterizada por uma perda anormal da função renal, falha renal, taxa de filtração glomerular reduzido ou glomerulonefrite, em um canino, em que a doença renal é detectável usando pelo menos um biomarcador relevante isolado e medido de uma amostra de teste biológico tirada de tal canino. a invenção adicionalmente relaciona a composições, reagentes e kits para realizar os métodos específicos.
BR112012015693A 2009-12-23 2010-12-23 métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda BR112012015693A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28977309P 2009-12-23 2009-12-23
PCT/US2010/062031 WO2011079280A2 (en) 2009-12-23 2010-12-23 Compositions and methods for diagnosing and treating kidney disorders in a canine

Publications (2)

Publication Number Publication Date
BR112012015693A2 BR112012015693A2 (pt) 2018-05-29
BR112012015693A8 true BR112012015693A8 (pt) 2018-06-26

Family

ID=43927763

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012015693A BR112012015693A8 (pt) 2009-12-23 2010-12-23 métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda

Country Status (10)

Country Link
US (1) US9476868B2 (pt)
EP (1) EP2517020B1 (pt)
JP (2) JP6199558B2 (pt)
CN (1) CN102713632B (pt)
AU (1) AU2010336392B2 (pt)
BR (1) BR112012015693A8 (pt)
CA (1) CA2785406A1 (pt)
RU (1) RU2546016C2 (pt)
WO (1) WO2011079280A2 (pt)
ZA (2) ZA201204531B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3054301A1 (en) * 2010-06-03 2016-08-10 Idexx Laboratories, Inc. Markers for renal disease
US9255296B2 (en) 2011-02-24 2016-02-09 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a feline
US20140309167A1 (en) * 2011-11-09 2014-10-16 Universita ; Degli Studi Bari Combination of active ingredients for the treatment of acute kidney injury
KR101609113B1 (ko) * 2013-11-20 2016-04-05 영동제약 주식회사 신부전증 진단용 키트 및 그 방법
CN106164089B (zh) * 2014-04-02 2020-11-03 日东电工株式会社 靶向分子及其用途
AR107786A1 (es) 2016-03-02 2018-06-06 Idexx Lab Inc Métodos y composiciones para la detección y el diagnóstico de enfermedad renal y enfermedad periodontal
WO2018094221A1 (en) * 2016-11-18 2018-05-24 Mayo Foundation For Medical Education And Research Assessing and treating fibrillary glomerulonephritis
JP2018096710A (ja) * 2016-12-08 2018-06-21 国立大学法人金沢大学 血中タンパク質を測定することにより、ネフローゼ症候群の疾患活動性を判定する方法
CN109293763B (zh) * 2018-10-26 2021-10-26 中国农业科学院特产研究所 水貂激活素b蛋白及其制备与应用
KR102167792B1 (ko) * 2019-10-01 2020-10-19 대한민국 개의 고칼슘혈증 조기 예측 또는 진단용 조성물
CN111733140B (zh) * 2020-04-04 2022-07-01 华中农业大学 一种抗犬基质金属蛋白酶的杂交瘤细胞株及其制备方法和一种单克隆抗体及其应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60153762A (ja) 1984-01-24 1985-08-13 Nippon Nousan Kogyo Kk 家畜、家禽用飼料
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5856092A (en) 1989-02-13 1999-01-05 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP1086742B2 (en) 1991-11-22 2007-03-14 Affymetrix, Inc. (a Delaware Corporation) Combinatorial strategies for polymer synthesis
US5541061A (en) 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
JP3954092B2 (ja) 1993-06-25 2007-08-08 アフィメトリックス インコーポレイテッド 核酸配列のハイブリダイゼーションと配列決定
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
JPH08191668A (ja) 1994-11-18 1996-07-30 Lion Corp ペットフード
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
US6811995B1 (en) 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
US6210912B1 (en) 1996-08-01 2001-04-03 Nippon Kayaku Kabushiki Kaisha Method for examining chronic rejection reactions following organ transplantation and method for determining urine components
DE69833758T2 (de) 1997-06-13 2006-08-31 Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara Verfahren zur erkennung von genpolymorphismen und allelexpression unter verwendung von sondenchips
US6333179B1 (en) 1997-06-20 2001-12-25 Affymetrix, Inc. Methods and compositions for multiplex amplification of nucleic acids
DE69829402T2 (de) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara Expressionsprofile in adulten und fötalen organen
US6013449A (en) 1997-11-26 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Probe-based analysis of heterozygous mutations using two-color labelling
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
AU769669B2 (en) 1998-09-02 2004-01-29 Heska Corporation Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism
US7763580B2 (en) 1999-01-05 2010-07-27 University Of Utah Research Foundation Methods for treating conditions associated with the accumulation of excess extracellular matrix
US6177248B1 (en) 1999-02-24 2001-01-23 Affymetrix, Inc. Downstream genes of tumor suppressor WT1
US6300070B1 (en) 1999-06-04 2001-10-09 Mosaic Technologies, Inc. Solid phase methods for amplifying multiple nucleic acids
WO2001088544A2 (en) * 2000-05-17 2001-11-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Proteolytic enzymes in diagnosis of kidney disorders
WO2002006537A2 (en) 2000-07-13 2002-01-24 Curagen Corporation Methods of identifying renal protective factors
WO2002079489A2 (en) 2001-03-30 2002-10-10 Curagen Corporation Method of identifying renalgenerative agents using differential gene expression
WO2002085285A2 (en) * 2001-04-18 2002-10-31 Wyeth Methods and reagents for regulating bone and cartilage formation
EP1401869B1 (en) 2001-06-01 2007-12-26 Biogen Idec MA Inc. Molecules and methods for inhibiting shedding of kim-1
AU2002362055A1 (en) 2001-12-03 2003-06-17 Oncomedx, Inc. Detection of matrix metalloproteinase rna in plasma and serum
WO2003097615A1 (en) 2002-05-17 2003-11-27 Scios, Inc. TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-β INHIBITORS
GB0215509D0 (en) 2002-07-04 2002-08-14 Novartis Ag Marker genes
WO2004005934A2 (en) 2002-07-04 2004-01-15 Oxford Glycosciences (Uk) Ltd Toxicity markers
WO2005002416A2 (en) 2003-06-04 2005-01-13 Joslin Diabetes Center, Inc. Predictors of renal disease
WO2006089268A2 (en) * 2005-02-18 2006-08-24 The University Of North Carolina At Chapel Hill Gene and cognate protein profiles and methods to determine connective tissue markers in normal and pathologic conditions
US20060253262A1 (en) * 2005-04-27 2006-11-09 Emiliem Novel Methods and Devices for Evaluating Poisons
WO2007041610A2 (en) 2005-09-30 2007-04-12 National Jewish Medical And Research Center Genes and proteins associated with angiogenesis and uses thereof
EP1808694A1 (en) * 2006-01-17 2007-07-18 Universitätsklinikum Freiburg Method for diagnosing polycystic kidney disease
TW200728718A (en) 2006-01-20 2007-08-01 Nat Defense Medical Ct Biomarkers for diagnosis of crescentic glomerulonephritis

Also Published As

Publication number Publication date
JP6199558B2 (ja) 2017-09-20
US9476868B2 (en) 2016-10-25
EP2517020B1 (en) 2015-10-21
CN102713632A (zh) 2012-10-03
JP2013515489A (ja) 2013-05-09
RU2546016C2 (ru) 2015-04-10
EP2517020A2 (en) 2012-10-31
WO2011079280A3 (en) 2011-11-17
ZA201407857B (en) 2015-04-29
WO2011079280A2 (en) 2011-06-30
RU2012131367A (ru) 2014-01-27
US20120283129A1 (en) 2012-11-08
JP6174777B2 (ja) 2017-08-02
AU2010336392B2 (en) 2014-01-23
JP2017079763A (ja) 2017-05-18
ZA201204531B (en) 2015-08-26
CA2785406A1 (en) 2011-06-30
CN102713632B (zh) 2015-10-07
BR112012015693A2 (pt) 2018-05-29
AU2010336392A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
BR112012015693A8 (pt) métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda
BR112014007214A2 (pt) predição de evento de risco cardiovascular e utilização do mesmo
Matjusaitis et al. Biomarkers to identify and isolate senescent cells
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
BR112012021202A2 (pt) aparelho e metodos para preparacao, reacao e deteccao integradas de amostras
BR112012011230A2 (pt) fatores de risco e previsão de infarto do miocárdio
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
BR112014011818A2 (pt) método para realizar ensaios de quantificação
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP4235181A3 (en) Biomarker detection process and assay of neurological condition
NZ704383A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010148391A3 (en) Biomarker assay of neurological condition
NZ700695A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2009139295A (ru) Биомаркеры и биомаркерные признаки почечной сохранности, обладающие предсказательной силой, для использования в мониторинге состояния почек
GB201317714D0 (en) Method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for the in vitro determination
ATE554389T1 (de) Apex als marker für lungenkrebs
NZ705411A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DK1974210T3 (da) Fremgangsmåde til diagnosticering af polycystisk nyresygdom
NZ624614A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010099137A3 (en) In situ methods for monitoring the emt status of tumor cells in vivo
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
WO2010136163A8 (en) Secernin-1 as a marker for cancer
BR112022007996A2 (pt) Métodos para o tratamento e uso de biomarcadores para predizer a sensibilidade clínica à 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018.